A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch.
about
A practical algorithm for managing Alzheimer's disease: what, when, and why?Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factorsMemoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's diseaseThe Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Potential role of the combination of galantamine and memantine to improve cognition in schizophreniaSwitching from oral donepezil to rivastigmine transdermal patch in Alzheimer's disease: 20-week extension phase results.Highlighting differences between conditional and unconditional quantile regression approaches through an application to assess medication adherence.Predictors of sustained response to rivastigmine in patients with Alzheimer's disease: a retrospective analysis.A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease.Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease.An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.Real-world evaluation of compliance and preference in Alzheimer's disease treatment.Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study.Caregiver burden and psychoeducational interventions in Alzheimer's disease: a review.Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan.The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia.Once-daily transdermal rivastigmine in the treatment of Alzheimer's disease.Turning principles into practice in Alzheimer's disease.Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease.Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type.Transdermal patches for the treatment of neurologic conditions in elderly patients: a review.Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain.Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.Current advances in transdermal delivery of drugs for Alzheimer's disease.The effect of vascular risk factors on the efficacy of rivastigmine patch and capsule treatment in Alzheimer's disease.Caregiver Preference and Treatment Compliance in Patients with Mild-to-Moderate Alzheimer's Disease in South Korea: RECAP Study Results.Continuous treatment with antidementia drugs in Germany 2003-2013: a retrospective database analysis.Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease.Medication adherence survey of drugs useful in prevention of dementia of Alzheimer's type among Indian patients.Biodegradable donepezil lipospheres for depot injection: optimization and in-vivo evaluation.Transdermal is better than oral: observational research of the satisfaction of caregivers of patients with Alzheimer's disease treated with rivastigmine.Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease.Clinical compliance of donepezil in treating Alzheimer's disease in taiwan.A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease.Impact of rivastigmine patch and capsules on activities of daily living in Alzheimer's disease.Which rivastigmine formula is better for heart in elderly patients with Alzheimer's disease: oral or patch?Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors.Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer’s disease
P2860
Q26859831-960025D7-50CC-4695-B5C5-C76F76824DD4Q26997299-19282E18-604C-4D78-B493-6E56A09C09C6Q28820783-A2507F2F-2AD7-4414-8249-4F664088625EQ33165801-6C4E849F-1A1D-47B9-9D2F-4C455CB9F6C5Q33905343-D0E3B482-A8CA-4359-99AD-83D1CD7F59E0Q34516224-935FEE70-88B2-422C-A125-B85BBB8A92DFQ34809210-24A88E52-4835-42CD-A152-CE4F122A13D5Q35252005-2359D2D2-C18B-4D6A-A45C-B4E6A4DCC3F2Q35428213-4CCC60FC-459B-4DAC-8F04-CC3374B44AADQ35539649-A95FCD9C-75AA-40B2-ABB8-1DA1C7AF70B1Q36173759-C845D18F-B1A4-4A98-9DC8-0C5330ED1467Q36264977-20C7D6D4-D3B2-4CAC-963C-F28A6D198636Q36383025-ABACAF04-F564-4B36-B738-26972E582FFAQ36551398-D48D7CC0-789E-4A1A-967F-FC5805262D89Q36766861-4AE468FF-0404-44B9-9F14-17F215C7EE3EQ36923575-FA8C5DF1-AEE3-4D36-9D72-20F0C97E4767Q36998823-1DDF07ED-DE96-45F4-8A86-90279A33A8D0Q37385577-0F2CFFA4-EC78-4DBB-B81D-A4A510FBB7CEQ37763287-AA1CE54B-B4E7-4453-986A-CD8E72FBF452Q37816073-B3114576-921B-4A21-9616-99FB34CA4150Q37895257-AA6BF704-1173-445E-9326-85D90D18689FQ37997774-4DDB873F-0989-41C4-B5BA-35059ABA3B6BQ38198100-2B888783-A6BE-426C-B7D1-36D2EBFDDB0CQ38350602-91E96F18-39E7-4FB0-94F1-54E989ED0E95Q38657942-7D0E35A1-5A43-42FC-A684-2703B18D1FDFQ38801735-6232052F-0DD4-4D58-B8C9-673300FC981BQ39079324-451AA4AF-ECA7-4277-AC2A-760000D090F6Q41032305-B226A472-7846-4367-A3DC-D08016A97760Q42668931-37E71F0D-D944-45CD-BD0D-77B96C7E1B39Q43609548-F49738D4-911D-44F1-AC98-C34CB0A860E3Q43622264-865B32E6-7817-4341-98F4-8D805A4D0585Q44014924-F21FAE7F-703F-4A5C-AA92-8D7950F5AD24Q45803280-F26A3F60-E423-4B18-A1BE-1E2F08DFD5A2Q46085226-100C0F6B-3E07-4502-88E4-A4AFB9C54850Q50614178-215BDE0F-27F1-4E3E-94ED-EA50324DE1B0Q50799612-4F3CB465-0FCB-41F0-B588-B36A56FB21BCQ53159751-B5688F06-720E-4C0E-B4E0-1E37AF89E2A5Q53464972-1031CCD5-A856-4C0D-A981-0758A1C5AFA2Q53818666-73229873-672C-4391-AFF1-AD733AE1A315Q57814526-E6E3885A-F818-42C3-9C57-1F854285D002
P2860
A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A review of compliance to trea ...... nefits of a transdermal patch.
@en
type
label
A review of compliance to trea ...... nefits of a transdermal patch.
@en
prefLabel
A review of compliance to trea ...... nefits of a transdermal patch.
@en
P356
P1476
A review of compliance to trea ...... nefits of a transdermal patch.
@en
P2093
Gary Small
P304
P356
10.1185/030079907X233403
P407
P50
P577
2007-11-01T00:00:00Z